Q/C TECHNOLOGIES, INC.

QCLS · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
279
SEC Filings

Business Summary

PART I . TNF is a clinical stage pharmaceutical company committed to extending healthy lifespan. TNF is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets, Isomyosamine and Supera-CBD: Isomyosamine is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including (but not limited to) sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, an...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionQCLSdiscussed_in_filing Cybersecurity
topic_mentionQCLSdiscussed_in_filing Trusted Computing
topic_mentionQCLSdiscussed_in_filing Blockchain & Crypto
topic_mentionQCLSdiscussed_in_filing Capital Expenditure
topic_mentionQCLSdiscussed_in_filing Regulation
topic_mentionQCLSdiscussed_in_filing Healthcare & Bio
topic_mentionQCLSdiscussed_in_filing Platform & Ecosystem
topic_mentionQCLSdiscussed_in_filing Cybersecurity
topic_mentionQCLSdiscussed_in_filing Trusted Computing
topic_mentionQCLSdiscussed_in_filing Blockchain & Crypto
topic_mentionQCLSdiscussed_in_filing Capital Expenditure
topic_mentionQCLSdiscussed_in_filing Regulation
topic_mentionQCLSdiscussed_in_filing Healthcare & Bio
topic_mentionQCLSdiscussed_in_filing Platform & Ecosystem
topic_mentionQCLSdiscussed_in_filing Cybersecurity
topic_mentionQCLSdiscussed_in_filing Trusted Computing
topic_mentionQCLSdiscussed_in_filing Blockchain & Crypto
topic_mentionQCLSdiscussed_in_filing Capital Expenditure
topic_mentionQCLSdiscussed_in_filing Regulation
topic_mentionQCLSdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-112024-12-310001641172-25-003814EDGAR133K words
2024-04-012023-12-310001493152-24-012533EDGAR—
2023-03-312022-12-310001493152-23-010384EDGAR—
2022-03-312021-12-310001493152-22-008546EDGAR—
2021-03-012020-12-310001493152-21-005129EDGAR—
2020-03-252019-12-310001493152-20-004650EDGAR—
2019-04-012018-12-310001493152-19-004590EDGAR—
2018-04-032017-12-310001493152-18-004626EDGAR—
2017-04-112016-12-310001493152-17-003722EDGAR—
2016-03-302015-12-310001493152-16-008364EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-192025-09-300001493152-25-024320EDGAR61K words
2025-08-192025-06-300001641172-25-024859EDGAR—
2025-05-152025-03-310001641172-25-010937EDGAR—
2024-11-142024-09-300001493152-24-046026EDGAR—
2024-08-192024-06-300001493152-24-032940EDGAR—
2024-05-152024-03-310001493152-24-019976EDGAR—
2023-11-142023-09-300001493152-23-041328EDGAR—
2023-08-142023-06-300001493152-23-028603EDGAR—
2023-05-152023-03-310001493152-23-017488EDGAR—
2022-11-102022-09-300001493152-22-031423EDGAR—
2022-08-152022-06-300001493152-22-022611EDGAR—
2022-05-162022-03-310001493152-22-013927EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-130001493152-26-010070EDGAR1K words
2026-01-230001493152-26-003440EDGAR—
2025-12-090001493152-25-026798EDGAR—
2025-11-140001493152-25-023596EDGAR—
2025-10-030001493152-25-016927EDGAR—
2025-09-260001493152-25-015774EDGAR—
2025-09-100001641172-25-027052EDGAR—
2025-09-020001641172-25-026167EDGAR—
2025-06-060001641172-25-014103EDGAR—
2025-05-090001641172-25-009514EDGAR—

279 total filings indexed. 247 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0001321834
TickerQCLS
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7aa35f71ca7e0612d27302c44ebb2b45aada3800b8cfe8c050c0dcdaadff4bb6
parent: da66df51188c112b91badf3764fc9cd63ef8180a5968dc471735668c79cca1f0
content hash: 82de6e7f5fd4f025dad01ec9d13341ab0598211f54e90a572ed8214f32c10add
signed: 2026-04-13T04:47:04.508Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf